Answer
Breastfeeding should be discontinued during treatment with CRESEMBA (isavuconazonium sulfate), because animal data show excretion of isavuconazole/metabolites in milk and a risk to newborns and infants cannot be excluded.
Sources for this answer
- CRESEMBA 200mg Powder for concentrate for solution for infusionPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 22Document updated
Sources checked